Back to results
US 8,008,451 B2Granted
Antibodies to TNF (tumor necrosis factor) receptor family members
AssigneeOno Pharmaceutical Co., Ltd.
InventorsHideaki Tada, Mikio Konishi, Daikichi Fukushima
Life of this patent
Estimating the term…
Abstract
Polypeptide produced from human stromal cell line, the process for the preparation of the polypeptide, DNA encoding the polypeptide, vector carrying the DNA, host cell transformed by the vector, antibody of the polypeptide, and pharmaceutical composition containing the polypeptide or the antibody.
Claims5
An isolated monoclonal or polyclonal antibody that specifically binds to a polypeptide selected from the group consisting of:
- (a) a polypeptide comprising the amino acid sequence of SEQ ID NO:4;
- (b) a polypeptide comprising the amino acid sequence of SEQ ID NO:8;
- (c) a polypeptide comprising the amino acid sequence of residues 1 to 392 of SEQ ID NO:4;
- (d) a polypeptide comprising the amino acid sequence of residues 1 to 398 of SEQ ID NO:8;
- (e) a polypeptide comprising an amino acid sequence having at least 95% amino acid identity with the amino acid sequence of SEQ ID NO:4;
- (f) a polypeptide comprising an amino acid sequence having at least 95% amino acid identity with the amino acid sequence of SEQ ID NO:8;
- (g) a polypeptide comprising an amino acid sequence having at least 95% amino acid identity with the amino acid sequence of residues 1 to 392 of SEQ ID NO:4;
- and
- (h) a polypeptide comprising an amino acid sequence having at least 95% amino acid identity with the amino acid sequence of residues 1 to 398 of SEQ ID NO:8;
- wherein said polypeptides are TNF (tumor necrosis factor) receptor family members.
7 more elements
Dependencies are inferred from the claim text.